The CF-ABLE Score

Ramsey, 1996, Management of pulmonary disease in patients with cystic fibrosis [published correction in N Engl J Med. 1996;335(15):1167], N Engl J Med, 335, 179, 10.1056/NEJM199607183350307 Corey, 1997, Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis, J Pediatr, 131, 809, 10.1016/S0022-3476(97)70025-8 Rosenbluth, 2004, Lung function decline in cystic fibrosis patients and timing for lung transplantation referral, Chest, 126, 412, 10.1378/chest.126.2.412 Amadori, 2009, Recurrent exacerbations affect FEV(1) decline in adult patients with cystic fibrosis, Respir Med, 103, 407, 10.1016/j.rmed.2008.09.024 Sanders, 2011, Pulmonary exacerbations are associated with subsequent FEV1 decline in both adults and children with cystic fibrosis, Pediatr Pulmonol, 46, 393, 10.1002/ppul.21374 Kerem, 1992, Prediction of mortality in patients with cystic fibrosis, N Engl J Med, 326, 1187, 10.1056/NEJM199204303261804 VanDevanter, 2010, Pulmonary outcome prediction (POP) tools for cystic fibrosis patients, Pediatr Pulmonol, 45, 1156, 10.1002/ppul.21311 Liou, 2001, Predictive 5-year survivorship model of cystic fibrosis, Am J Epidemiol, 153, 345, 10.1093/aje/153.4.345 Taussig, 1973, A new prognostic score and clinical evaluation system for cystic fibrosis, J Pediatr, 82, 380, 10.1016/S0022-3476(73)80110-6 Hafen, 2006, Clinical scoring systems in cystic fibrosis, Pediatr Pulmonol, 41, 602, 10.1002/ppul.20376 Fogarty, 2012, Are measures of body habitus associated with mortality in cystic fibrosis?, Chest, 142, 712, 10.1378/chest.11-2124 Courtney, 2007, Predictors of mortality in adults with cystic fibrosis, Ped Pulmonol, 42, 525, 10.1002/ppul.20619 Milla, 1998, Risk of death in cystic fibrosis patients with severely compromised lung function, Chest, 113, 1230, 10.1378/chest.113.5.1230 Mayer-Hamblett, 2002, Developing cystic fibrosis lung transplant referral criteria using predictors of 2-year mortality, Am J Respir Crit Care Med, 166, 1550, 10.1164/rccm.200202-087OC Konstan, 2007, Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis, J Pediatr, 151, 134, 10.1016/j.jpeds.2007.03.006 Waters, 2012, Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis, Eur Respir J, 40, 61, 10.1183/09031936.00159111 de Boer, 2011, Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis, Thorax, 66, 680, 10.1136/thx.2011.161117 Shwachman, 1958, Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period, AMA J Dis Child, 96, 6, 10.1001/archpedi.1958.02060060008002 Doershuk, 1964, A 5 year clinical evaluation of a therapeutic program for patients with cystic fibrosis, J Pediatr, 65, 677, 10.1016/S0022-3476(64)80152-9 Cooperman, 1971, A simplified cystic fibrosis scoring system (a preliminary report), Can Med Assoc J, 105, 580